Larry Xi,
CEO and CSO
Dr. Larry Xi worked on PCR-related technologies for more than a dozen years following a career path of “M-B-A” (acronym of MJ Research, BioRad, and ABI). These three companies once had combined 80% of PCR market. In 2013, he joined Fluidigm In his after-Life (when ABI merged into Life Technologies). He invented BIG (barcoding-in-Genome) technology when working for Fluidigm. In 2017, he acquired the right to BIG and formed Digenomix Corp, and has served as CEO and CSO.
|
|
|
